Although CTCs possess a greater predictive value than CA125 for early tumor stages (IA-IB) [263], they display low survival rates in blood circulation, making them more suitable for monitoring disease progression or metastasis [269,270] than for early detection [271]. The gene discussed is MUC16; the disease is neoplasm.